Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) Equity Average (2023 - 2025)

Upstream Bio has reported Equity Average over the past 3 years, most recently at $359.2 million for Q4 2025.

  • Quarterly results put Equity Average at $359.2 million for Q4 2025, up 132.07% from a year ago — trailing twelve months through Dec 2025 was $359.2 million (up 132.07% YoY), and the annual figure for FY2025 was $404.8 million, up 133.51%.
  • Equity Average for Q4 2025 was $359.2 million at Upstream Bio, down from $393.7 million in the prior quarter.
  • Over the last five years, Equity Average for UPB hit a ceiling of $457.7 million in Q1 2025 and a floor of -$153.5 million in Q3 2024.
  • Median Equity Average over the past 3 years was $154.8 million (2024), compared with a mean of $139.2 million.
  • Peak annual rise in Equity Average hit 456.86% in 2025, while the deepest fall reached 132.07% in 2025.
  • Upstream Bio's Equity Average stood at -$117.7 million in 2023, then surged by 231.53% to $154.8 million in 2024, then surged by 132.07% to $359.2 million in 2025.
  • The last three reported values for Equity Average were $359.2 million (Q4 2025), $393.7 million (Q3 2025), and $427.2 million (Q2 2025) per Business Quant data.